{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:57:36Z","timestamp":1793843856195,"version":"4.6.1"},"reference-count":246,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.autrev.2020.102735","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T22:24:49Z","timestamp":1608243889000},"page":"102735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":380,"title":["Beyond the joints, the extra-articular manifestations in rheumatoid arthritis"],"prefix":"10.1016","volume":"20","author":[{"given":"Alessandro","family":"Conforti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Di Cola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Pavlych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onorina","family":"Berardicurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ursini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9746","key":"10.1016\/j.autrev.2020.102735_bb0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jbspin.2016.07.007","article-title":"Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review","volume":"83","author":"Minichiello","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"10055","key":"10.1016\/j.autrev.2020.102735_bb0015","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis [published correction appears in Lancet. 2016 Oct 22;388(10055):1984]","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.autrev.2020.102735_bb0020","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.rcl.2017.04.006","article-title":"Computed tomography and MR imaging in rheumatoid arthritis","volume":"55","author":"Barile","year":"2017","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.autrev.2020.102735_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/782382","article-title":"The role of IL-1\u03b2 in the bone loss during rheumatic diseases","volume":"2015","author":"Ruscitti","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000493390","article-title":"Rheumatoid arthritis: a brief overview of the treatment","volume":"27","author":"Bullock","year":"2018","journal-title":"Med Princ Pract"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/rheumatology\/keu398","article-title":"Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study","volume":"54","author":"Giacomelli","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","author":"Ingegnoli","year":"2013","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/art.37720","article-title":"The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and \u03b2-actin","volume":"65","author":"van Beers","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00281-017-0627-z","article-title":"The role of autoantibodies in the pathophysiology of rheumatoid arthritis","volume":"39","author":"Derksen","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.clinthera.2014.01.014","article-title":"Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms","volume":"36","author":"Cipriani","year":"2014","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.autrev.2020.102735_bb0065","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1586\/1744666X.2014.962996","article-title":"Methotrexate: an old new drug in autoimmune disease","volume":"10","author":"Cipriani","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/17512433.2020.1772055","article-title":"Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy","volume":"13","author":"Berardicurti","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0075","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0080","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/art.38344","article-title":"Hand and foot surgery rates in rheumatoid arthritis have declined from 1986 to 2011, but large-joint replacement rates remain unchanged: results from two UK inception cohorts","volume":"66","author":"Nikiphorou","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0085","first-page":"81","article-title":"An overview of the extraarticular involvement in rheumatoid arthritis and its management","volume":"8","author":"Das","year":"2017","journal-title":"J Pharmacol Pharmacother"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0090","first-page":"286","article-title":"Extra-articular manifestations in rheumatoid arthritis","volume":"5","author":"Cojocaru","year":"2010","journal-title":"Maedica (Buchar)"},{"key":"10.1016\/j.autrev.2020.102735_bb0095","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/38.7.668","article-title":"Extra-articular rheumatoid arthritis: prevalence and mortality","volume":"38","author":"Turesson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2011.09.001","article-title":"Extra-articular manifestations of rheumatoid arthritis: an update","volume":"11","author":"Prete","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0105","first-page":"243","article-title":"Skin manifestations of rheumatoid arthritis","volume":"153","author":"Lora","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2004.07.023","article-title":"Rheumatoid arthritis: a review of the cutaneous manifestations","volume":"53","author":"Sayah","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780330601","article-title":"The rheumatoid nodule","volume":"33","author":"Ziff","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102735_bb0120","series-title":"Pathology. Rheumatoid arthritis: an illustrated guide to pathology, diagnosis, and management","first-page":"28","volume":"vol. 4","author":"Schumacher","year":"1988"},{"key":"10.1016\/j.autrev.2020.102735_bb0125","series-title":"Rheumatoid arthritis: etiology, diagnosis, management","first-page":"331","article-title":"Extra-articular rheumatoid arthritis: clinical features and treatment overview","author":"Bernhard","year":"1985"},{"key":"10.1016\/j.autrev.2020.102735_bb0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0002-9343(84)90787-3","article-title":"Rheumatoid nodules. Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases","volume":"76","author":"Kaye","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0135","series-title":"Arthritis and allied conditions","article-title":"Extra-articular rheumatoid disease","author":"Decker","year":"1979"},{"key":"10.1016\/j.autrev.2020.102735_bb0140","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1172\/JCI115814","article-title":"Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis","volume":"89","author":"Weyand","year":"1992","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.det.2015.03.004","article-title":"Rheumatoid Nodules","volume":"33","author":"Tilstra","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.autrev.2020.102735_bb0150","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/rheumatology\/kem163","article-title":"Stamp l. The rheumatoid nodule: peripheral or central to rheumatoid arthritis?","volume":"46","author":"Highton","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2020.102735_bb0155","first-page":"1839","article-title":"Complement mediated vascular endothelial injury in rheumatoid nodules: a histopathological and immunohistochemical study","volume":"27","author":"Kato","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clim.2016.07.002","article-title":"A possible pathogenetic role of IL-23\/IL-17 axis in rheumatoid nodules in patients with rheumatoid arthritis","volume":"170","author":"Saito-Sasaki","year":"2016","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0165","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00330-018-5755-x","article-title":"Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy","volume":"29","author":"Koslow","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.autrev.2020.102735_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(73)90040-5","article-title":"The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases","volume":"54","author":"Gordon","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0175","series-title":"Diagnosis and management of rheumatoid arthritis","author":"Calin","year":"1983"},{"key":"10.1016\/j.autrev.2020.102735_bb0180","first-page":"867","article-title":"Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis","volume":"19","author":"Kerstens","year":"1992","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.8.1.1","article-title":"A variant of rheumatoid arthritis characterized by recurrent digital pad nodules and palmar fasciitis, closely resembling palindromic rheumatism","volume":"8","author":"Bywaters","year":"1949","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102735_bb0190","first-page":"1427","article-title":"Rheumatoid nodulosis: report of two new cases and discussion of diagnostic criteria","volume":"15","author":"Couret","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0195","first-page":"736","article-title":"Complete reversal of rheumatoid nodulosis","volume":"18","author":"McCarty","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0200","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.1780290702","article-title":"The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis","volume":"29","author":"Kremer","year":"1986","journal-title":"Arthritis Rheum"},{"issue":"2 Pt 2","key":"10.1016\/j.autrev.2020.102735_bb0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0190-9622(98)70390-1","article-title":"Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis","volume":"39","author":"Williams","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0049-0172(80)90014-1","article-title":"Felty syndrome","volume":"10","author":"Goldberg","year":"1980","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2020.102735_bb0215","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/art.1780220908","article-title":"The rarity of Felty\u2019s syndrome in blacks","volume":"22","author":"Termini","year":"1979","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0220","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.berh.2004.05.002","article-title":"Felty\u2019s syndrome","volume":"18","author":"Balint","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102735_bb0225","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/rheumatology\/33.11.1078","article-title":"Leg ulceration in rheumatoid arthritis","volume":"33","author":"McRorie","year":"1994","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-120-1-199401010-00006","article-title":"Incidence of cancer among men with the Felty syndrome","volume":"120","author":"Gridley","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0235","unstructured":"Crowley JP. Felty's syndrome. Utsinger PD, Zvaifler NJ, Ehrlich GE, editors. Rheumatoid arthritis: etiology, diagnosis, management. Philadelphia: JB Lippincott Co."},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0240","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jbspin.2014.12.001","article-title":"Treatment of pseudo Felty\u2019s syndrome: is there place for rituximab?","volume":"82","author":"Verhoeven","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2020.102735_bb0245","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.13.2.136","article-title":"The arteritis of rheumatoid arthritis","volume":"13","author":"Cruickshank","year":"1954","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0250","first-page":"448","article-title":"Rheumatoid arthritis\u2014the clinical significance of histo- and immunopathological abnormalities in normal skin","volume":"11","author":"Westedt","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0255","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/rheumatology\/24.4.340","article-title":"Direct immunofluorescence of normal skin rheumatoid arthritis","volume":"24","author":"Fitzgerald","year":"1985","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0260","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00005792-198107000-00004","article-title":"Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases","volume":"60","author":"Scott","year":"1981","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2020.102735_bb0265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02041550","article-title":"Rheumatoid vasculitis: diagnostic and therapeutic decisions","volume":"2","author":"Panush","year":"1983","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0270","first-page":"128","article-title":"New insight into the rheumatoid vasculitis","volume":"53","author":"Cojocaru","year":"2015","journal-title":"Rom J Intern Med"},{"issue":"9","key":"10.1016\/j.autrev.2020.102735_bb0275","first-page":"e5790","article-title":"Rheumatoid vasculitis: is it always a late manifestation of rheumatoid arthritis?","volume":"11","author":"Anwar","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2020.102735_bb0280","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.16.1.84","article-title":"Peripheral vascular obstruction in rheumatoid arthritis and its relationships to other vascular lesions","volume":"16","author":"Bywaters","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102735_bb0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.1965.tb14632.x","article-title":"Arteritis of rheumatoid arthritis","volume":"77","author":"Golding","year":"1965","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102735_bb0290","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard.54.11.927","article-title":"Isolated nail fold vasculitis in rheumatoid arthritis","volume":"54","author":"Watts","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102735_bb0295","first-page":"507","article-title":"The frequency of leg ulceration in rheumatoid arthritis: a survey","volume":"10","author":"Thurtle","year":"1983","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0300","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0140-6736(00)03212-8","article-title":"NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis","volume":"356","author":"Tuveri","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102735_bb0305","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/rheumatology\/40.7.816","article-title":"Leg ulcers in patients with rheumatoid arthritis\u2014a prospective study of aetiology, wound healing and pain reduction after pinch grafting","volume":"40","author":"Oien","year":"2001","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0310","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semarthrit.2006.04.006","article-title":"Systemic rheumatoid vasculitis: a review","volume":"36","author":"Genta","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102735_bb0315","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0049-0172(85)90047-2","article-title":"Rheumatoid vasculitis: experience with 13 patients and review of the literature","volume":"14","author":"Schneider","year":"1985","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102735_bb0320","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.55.3.190","article-title":"Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study","volume":"55","author":"Voskuyl","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102735_bb0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis","volume":"76","author":"Scott","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0330","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/ard.46.10.727","article-title":"Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications","volume":"46","author":"Geirsson","year":"1987","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0335","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1365-2133.2002.04933.x","article-title":"Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis","volume":"147","author":"Chen","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0340","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/acr.20689","article-title":"Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: results from the AutoImmunity and Rituximab Registry","volume":"64","author":"Pu\u00e9chal","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2020.102735_bb0345","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2007.081679","article-title":"Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis","volume":"67","author":"Pu\u00e9chal","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0350","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00393-009-0577-5","article-title":"Erkrankungen des \u00e4usseren Auges bei rheumatoider arthritis [diseases of the outer eye in rheumatoid arthritis]","volume":"69","author":"Feist","year":"2010","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0355","first-page":"393","article-title":"Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies","volume":"9","author":"Vignesh","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.autrev.2020.102735_bb0360","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-015-8518-3","article-title":"Ocular involvement in systemic autoimmune diseases","volume":"49","author":"General","year":"2015","journal-title":"Clinic Rev Allerg Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102735_bb0365","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00393-017-0372-7","article-title":"Augenbeteiligung bei rheumatoider Arthritis, Kollagenosen und Vaskulitiden [ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis]","volume":"76","author":"K\u00f6tter","year":"2017","journal-title":"Z Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0370","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0375","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.60.3.192","article-title":"Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis","volume":"60","author":"McGavin","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2020.102735_bb0380","series-title":"StatPearls","article-title":"Episcleritis","author":"Schonberg","year":"2020"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0385","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0390","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10384-019-00674-7","article-title":"Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis)","volume":"63","author":"Yoshida","year":"2019","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0395","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bjo.78.5.381","article-title":"Cells perpetuating the inflammatory response in scleritis","volume":"78","author":"Bernauer","year":"1994","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0400","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","article-title":"Scleritis and peripheral ulcerative keratitis","volume":"33","author":"Galor","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0405","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/09273948.2015.1032308","article-title":"Flurbiprofen: a nonselective cyclooxygenase (COX) inhibitor for treatment of noninfectious, non-necrotizing anterior scleritis","volume":"24","author":"Agrawal","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0410","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ophtha.2011.07.043","article-title":"Scleritis therapy","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0415","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102735_bb0420","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","article-title":"Mycophenolate mofetil for the treatment of scleritis","volume":"110","author":"Sen","year":"2003","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0425","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3129\/i09-061","article-title":"Infliximab for the treatment of active scleritis","volume":"44","author":"Sen","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102735_bb0430","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ophtha.2014.04.044","article-title":"Rituximab therapy for refractory scleritis: results of a phase I\/II dose-ranging, randomized, clinical trial","volume":"121","author":"Suhler","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0435","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","article-title":"Cyclophosphamide for ocular inflammatory diseases","volume":"117","author":"Pujari","year":"2010","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0440","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","article-title":"Scleritis and peripheral ulcerative keratitis","volume":"33","author":"Galor","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2020.102735_bb0445","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajo.2016.09.017","article-title":"Gevokizumab in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I\/II clinical trial","volume":"172","author":"Knickelbein","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102735_bb0450","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ophtha.2014.04.044","article-title":"Rituximab therapy for refractory scleritis: results of a phase I\/II dose-ranging, randomized, clinical trial","volume":"121","author":"Suhler","year":"2014","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.autrev.2020.102735_bb0455","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/bjo.83.8.941","article-title":"Incidence of corneal melting in association with systemic disease in the Yorkshire Region, 1995\u20137","volume":"83","author":"McKibbin","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102735_bb0460","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0465","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/1744666X.2014.907744","article-title":"Regulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis","volume":"10","author":"Maseda","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102735_bb0470","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2015\/951081","article-title":"In vivo confocal microscopy of the human cornea in the assessment of peripheral neuropathy and systemic diseases","volume":"2015","author":"Wang","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2020.102735_bb0475","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.ico.0000154391.28254.1d","article-title":"Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab","volume":"24","author":"Thomas","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.autrev.2020.102735_bb0480","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ard.2004.023283","article-title":"Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics","volume":"64","author":"Clewes","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0485","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1753425912471692","article-title":"Inflammation in dry eye associated with rheumatoid arthritis: cytokine and in vivo confocal microscopy study","volume":"19","author":"Villani","year":"2013","journal-title":"Innate Immun"},{"issue":"Suppl. 4","key":"10.1016\/j.autrev.2020.102735_bb0490","first-page":"S61","article-title":"Prevalence of dry eye syndrome and Sjogren\u2019s syndrome in patients with rheumatoid arthritis","volume":"95","author":"Kosrirukvongs","year":"2012","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0495","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/08830185.2012.748052","article-title":"Dry eye as a mucosal autoimmune disease","volume":"32","author":"Stern","year":"2013","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.autrev.2020.102735_bb0500","first-page":"221","article-title":"Report of the national eye institute\/ industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"issue":"7","key":"10.1016\/j.autrev.2020.102735_bb0505","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.58.7.415","article-title":"Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis","volume":"58","author":"Uhlig","year":"1999","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0510","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.10999","article-title":"A prospective study of sicca symptoms in patients with rheumatoid arthritis","volume":"49","author":"Brun","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102735_bb0515","doi-asserted-by":"crossref","first-page":"5768679","DOI":"10.1155\/2020\/5768679","article-title":"Study of factors influencing dry eye in rheumatoid arthritis","volume":"2020","author":"Ma","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.autrev.2020.102735_bb0520","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0049-0172(79)80005-0","article-title":"Extraarticular manifestations of rheumatoid arthritis","volume":"8","author":"Hurd","year":"1979","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2020.102735_bb0525","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","article-title":"Cardiovascular comorbidity in rheumatic diseases","volume":"11","author":"Nurmohamed","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2020.102735_bb0530","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11926-018-0790-9","article-title":"Cardiovascular and metabolic comorbidities in rheumatoid arthritis","volume":"20","author":"Romano","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0535","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13075-019-1975-y","article-title":"Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study","volume":"21","author":"Ruscitti","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0540","first-page":"234","article-title":"Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention","volume":"17","author":"Snow","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0545","doi-asserted-by":"crossref","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0550","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson","year":"2013","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.autrev.2020.102735_bb0555","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2015.40","article-title":"Atherosclerosis in rheumatoid arthritis: is it all about inflammation?","volume":"11","author":"Skeoch","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0560","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.eurheartj.a060892","article-title":"Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease","volume":"16","author":"Corrao","year":"1995","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.autrev.2020.102735_bb0565","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10067-009-1145-8","article-title":"Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis","volume":"28","author":"Ortega-Hernandez","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102735_bb0570","first-page":"553","article-title":"Acute pericarditis: diagnosis and management","volume":"89","author":"Snyder","year":"2014","journal-title":"Am Fam Physician"},{"issue":"10","key":"10.1016\/j.autrev.2020.102735_bb0575","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2459\/JCM.0b013e3283340b97","article-title":"Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis","volume":"11","author":"Imazio","year":"2010","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"42","key":"10.1016\/j.autrev.2020.102735_bb0580","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehv318","article-title":"The 2015 ESC guidelines on the diagnosis and management of pericardial diseases","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.autrev.2020.102735_bb0585","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0590","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar3131","article-title":"Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study","volume":"12","author":"Kobayashi","year":"2010","journal-title":"Arthrit Res Ther"},{"issue":"7","key":"10.1016\/j.autrev.2020.102735_bb0595","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11886-017-0870-x","article-title":"Myocarditis: a clinical overview","volume":"19","author":"Caforio","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0605","first-page":"683","article-title":"Cardiovascular and pupillary autonomic nervous dysfunction in patients with rheumatoid arthritis - a cross-sectional and longitudinal study","volume":"24","author":"Schwemmer","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0610","first-page":"84","article-title":"Population-based study of QT interval prolongation in patients with rheumatoid arthritis","volume":"33","author":"Chauhan","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0615","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/rheumatology\/kes262","article-title":"A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome","volume":"52","author":"Norton","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2020.102735_bb0620","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.rmed.2012.06.020","article-title":"Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis","volume":"106","author":"Wilsher","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0625","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.autrev.2020.102735_bb0630","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3899\/jrheum.150166","article-title":"A study of multiple causes of death in rheumatoid arthritis","volume":"42","author":"Pinheiro","year":"2015","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102735_bb0635","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.ejrad.2015.07.008","article-title":"Intra-thoracic rheumatoid arthritis: imaging spectrum of typical findings and treatment related complications","volume":"84","author":"Chansakul","year":"2015","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0640","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2020.102735_bb0645","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/759760","article-title":"The multifaceted aspects of interstitial lung disease in rheumatoid arthritis","volume":"2013","author":"Cavagna","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2020.102735_bb0650","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid-arthritis associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2020.102735_bb0655","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7915340","article-title":"Clinical, epidemiological, and histopathological features of respiratory involvement in rheumatoid arthritis","volume":"2017","author":"Alunno","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2020.102735_bb0660","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102735_bb0665","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/ard.56.10.596","article-title":"Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis","volume":"56","author":"Cortet","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102735_bb0670","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102735_bb0675","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001278","article-title":"Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis","volume":"6","author":"Joshua","year":"2020","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0680","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","article-title":"Pulmonary involvement in early rheumatoid arthritis patients","volume":"30","author":"Habib","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0685","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1759720X15612250","article-title":"Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review","volume":"7","author":"Iqbal","year":"2015","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"8","key":"10.1016\/j.autrev.2020.102735_bb0690","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJM200102223440805","article-title":"A mutation in the surfactant protein C gene associated with familial interstitial lung disease","volume":"344","author":"Nogee","year":"2001","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0695","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1183\/09031936.05.00133404","article-title":"Genetics of fibrosing lung diseases","volume":"25","author":"Grutters","year":"2005","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.autrev.2020.102735_bb0700","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"issue":"10","key":"10.1016\/j.autrev.2020.102735_bb0705","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.1780391014","article-title":"Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities","volume":"39","author":"Saag","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2020.102735_bb0710","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1164\/ajrccm.185.9.1024","article-title":"Methotrexate might increase mortality from interstitial lung disease in rheumatoid arthritis","volume":"185","author":"Toyoshima","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0715","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1517\/14740338.2011.560835","article-title":"Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury","volume":"10","author":"Inokuma","year":"2011","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0720","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0725","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MCP.0b013e3283483ea5","article-title":"Biological treatments and connective tissue disease associated interstitial lung disease","volume":"17","author":"Panopoulos","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0730","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/BOR.0000000000000238","article-title":"The lung in rheumatoid arthritis, cause or consequence?","volume":"28","author":"Chatzidionisyou","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0735","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/resp.12234","article-title":"Predictors of mortality in rheumatoid arthritis-related interstitial lung disease","volume":"19","author":"Assayag","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.autrev.2020.102735_bb0740","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0745","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.56.8.463","article-title":"Cigarette smoking and rheumatoid arthritis severity","volume":"56","author":"Saag","year":"1997","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2020.102735_bb0750","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/ard.49.10.753","article-title":"Smoking, lung function, and rheumatoid factors","volume":"49","author":"Tuomi","year":"1990","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0755","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1183\/09031936.00189309","article-title":"Smoking-related lung diseases: a clinical perspective","volume":"35","author":"Clinical Assembly contribution to the celebration of 20 years of the ERS","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0760","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ccm.2011.11.004","article-title":"Smoking-related interstitial lung diseases","volume":"33","author":"Vassallo","year":"2012","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0765","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.autrev.2020.102735_bb0770","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.autrev.2020.102735_bb0775","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0780","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10067-009-1128-9","article-title":"Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA","volume":"28","author":"Gizinski","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0785","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0790","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2015.01.013","article-title":"Citrullination and autoimmunity","volume":"14","author":"Valesini","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102735_bb0795","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1084\/jem.20131241","article-title":"A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis","volume":"210","author":"Scally","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0800","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/ard.2003.009969","article-title":"HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis","volume":"63","author":"Laivoranta-Nyman","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102735_bb0805","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","article-title":"Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA\u2013DR3 and the shared epitope alleles","volume":"52","author":"Irigoyen","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0810","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102735_bb0815","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0820","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.smim.2011.01.014","article-title":"Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis","volume":"23","author":"Klareskog","year":"2011","journal-title":"Semin Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102735_bb0825","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","article-title":"Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Restrepo","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0830","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3899\/jrheum.090303","article-title":"HLA-DRB1 alleles and rheumatoid arthritis-related pulmonary fibrosis","volume":"37","author":"Migita","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb0835","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2213-2600(14)70047-5","article-title":"Genetic determinants of pulmonary fibrosis: evolving concepts","volume":"2","author":"Spagnolo","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0840","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0845","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society and European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.autrev.2020.102735_bb0850","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrrheum.2014.149","article-title":"Interstitial lung disease in connective tissue disease\u2014mechanisms and management","volume":"10","author":"Wells","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0855","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1513\/pats.200602-019TK","article-title":"Histologic spectrum of idiopathic interstitial pneumonias","volume":"3","author":"Visscher","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.autrev.2020.102735_bb0860","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0865","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02314-2016","article-title":"Shared genetic predisposition in rheumatoid arthritis \u2013 interstitial lung disease and familial pulmonary fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0870","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1038\/s41467-018-07768-9","article-title":"Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice","volume":"9","author":"Hancock","year":"2018","journal-title":"Nat Commun."},{"issue":"16","key":"10.1016\/j.autrev.2020.102735_bb0875","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb0880","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2214\/ajr.171.6.9843306","article-title":"Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings","volume":"171","author":"Kim","year":"1998","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0885","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/rg.291085096","article-title":"Nonspecific interstitial pneumonia: radiologic, clinical, and pathologic considerations","volume":"29","author":"Kligerman","year":"2009","journal-title":"Radiographics"},{"issue":"12","key":"10.1016\/j.autrev.2020.102735_bb0890","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.200611-1685OC","article-title":"Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project","volume":"177","author":"Travis","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0895","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1148\/radiology.195.3.7753988","article-title":"Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in 7 patients","volume":"195","author":"Park","year":"1995","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0900","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-2004-815603","article-title":"Bronchiolar complications of connective tissue diseases","volume":"24","author":"White","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0905","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1183\/09031936.06.00013505","article-title":"Cryptogenic organising pneumonia","volume":"28","author":"Cordier","year":"2006","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0910","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jbspin.2007.10.009","article-title":"Organizing pneumonia after rituximab therapy: two cases","volume":"75","author":"Soubrier","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb0915","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10067-003-0848-5","article-title":"Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis","volume":"23","author":"Uluba\u015f","year":"2004","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0920","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/resp.12693","article-title":"Rare idiopathic interstitial pneumonias: LIP and PPFE and rare histologic patterns of interstitial pneumonias: AFOP and BPIP","volume":"21","author":"Kokosi","year":"2016","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0925","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0034-1371543","article-title":"Pulmonary pathology in connective tissue disease","volume":"35","author":"Urisman","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0930","first-page":"2013","article-title":"Lymphocytic interstitial pneumonia as a manifestation of SLE and secondary Sjogren\u2019s syndrome","author":"Garcia","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"128","key":"10.1016\/j.autrev.2020.102735_bb0935","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1183\/09059180.00005812","article-title":"Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology","volume":"22","author":"Godbert","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.autrev.2020.102735_bb0940","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2559.2004.01921.x","article-title":"Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking","volume":"45","author":"Craig","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.autrev.2020.102735_bb0945","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/thx.27.3.324","article-title":"Electron microscopic studies in desquamative interstitial pneumonia associated with asbestos","volume":"27","author":"Corrin","year":"1972","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2020.102735_bb0950","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1378\/chest.80.1_Supplement.67S","article-title":"Inorganic particles associated with desquamative interstitial pneumonia","volume":"80","author":"Abraham","year":"1981","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0955","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1378\/chest.130.2.553","article-title":"Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases","volume":"130","author":"Parambil","year":"2006","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0960","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1445-5994.1997.tb00981.x","article-title":"Diffuse alveolar damage following a single administration of a cyclophosphamide containing chemotherapy regimen","volume":"27","author":"Woolley","year":"1997","journal-title":"Aust N Z J Med"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb0965","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2169\/internalmedicine.31.674","article-title":"Follicular bronchiolitis associated with rheumatoid arthritis","volume":"31","author":"Kinoshita","year":"1992","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.autrev.2020.102735_bb0970","first-page":"OE01","article-title":"Follicular bronchiolitis: a literature review","volume":"9","author":"Tashtoush","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb0975","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12890-016-0269-2","article-title":"Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes","volume":"16","author":"Nurmi","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.autrev.2020.102735_bb0980","doi-asserted-by":"crossref","first-page":"708","DOI":"10.12659\/MSM.890880","article-title":"A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients","volume":"21","author":"Wang","year":"2015","journal-title":"Med Sci Monit"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb0985","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1756-185X.2009.01376.x","article-title":"Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease","volume":"12","author":"Mohd Noor","year":"2009","journal-title":"Int J Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2020.102735_bb0990","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thx.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb0995","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0007-0971(65)80050-X","article-title":"Rheumatoid interstitial lung disease","volume":"59","author":"Stack","year":"1965","journal-title":"Br J Dis Chest"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb1000","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.63.1.27","article-title":"Pulmonary dysfunction in rheumatoid disease","volume":"63","author":"Frank","year":"1973","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb1005","first-page":"170","article-title":"Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease","volume":"18","author":"Chetta","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb1010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-2007-991524","article-title":"Bronchoalveolar lavage to diagnose respiratory infections","volume":"28","author":"Ramirez","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb1015","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1183\/09031936.00152607","article-title":"Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement","volume":"33","author":"Antoniou","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/S0272-5231(05)70109-X","article-title":"Pulmonary manifestations of rheumatoid arthritis","volume":"19","author":"Tanoue","year":"1998","journal-title":"Clin Chest Med"},{"issue":"18","key":"10.1016\/j.autrev.2020.102735_bb1025","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1517\/14656560802591430","article-title":"Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease","volume":"9","author":"Kelly","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb1030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11926-010-0116-z","article-title":"Interstitial lung disease in rheumatoid arthritis","volume":"12","author":"Ascherman","year":"2010","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb1035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3346\/jkms.2002.17.2.270","article-title":"Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report","volume":"17","author":"Chang","year":"2002","journal-title":"J Korean Med Sci"},{"issue":"15","key":"10.1016\/j.autrev.2020.102735_bb1040","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archinte.168.15.1718","article-title":"Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug","volume":"168","author":"Saketkoo","year":"2008","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb1045","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb1050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0012-3692(15)50949-5","article-title":"Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease","volume":"130","author":"Swigris","year":"2006","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb1055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/resp.12214","article-title":"Rituximab in severe, treatment-refractory interstitial lung disease","volume":"19","author":"Keir","year":"2014","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb1060","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00296-012-2587-x","article-title":"Rituximab: rescue therapy in lifethreatening complications or refractory autoimmune diseases: a single center experience","volume":"33","author":"Braun-Moscovici","year":"2013","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.autrev.2020.102735_bb1065","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/rheumatology\/kel090","article-title":"Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment","volume":"45","author":"Lindsay","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"7477","key":"10.1016\/j.autrev.2020.102735_bb1070","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/bmj.329.7477.1266","article-title":"Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab","volume":"329","author":"Ostor","year":"2004","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb1075","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2009.120626","article-title":"Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb1080","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.4187\/respcare.02597","article-title":"Pleuro-pulmonary complications of rheumatoid arthritis","volume":"59","author":"Corcoran","year":"2014","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb1085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/40.3.350","article-title":"Secondary spontaneous pneumothorax in a patient with pulmonary rheumatoid nodules during treatment with methotrexate","volume":"40","author":"Gotsman","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102735_bb1090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/RHU.0000000000000244","article-title":"Pleural effusion, pneumothorax, and lung entrapment in rheumatoid arthritis","volume":"21","author":"Komarla","year":"2015","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb1095","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-2007-985664","article-title":"Pulmonary manifestations of rheumatoid arthritis","volume":"28","author":"Gauhar","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.autrev.2020.102735_bb1100","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.semarthrit.2006.03.002","article-title":"Rheumatoid pleural effusion","volume":"35","author":"Balbir-Gurman","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102735_bb1105","unstructured":"Chapman PT, O'Donnell JL, Moller PW. Rheumatoid pleural effusion: response to intrapleural corticosteroid. J Rheumatol."},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb1110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.radcr.2018.03.004","article-title":"A case of Caplan syndrome in a recently diagnosed patient with silicosis: a case report","volume":"13","author":"Alaya","year":"2018","journal-title":"Radiol Case Rep"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb1115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/thx.8.1.29","article-title":"Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis","volume":"8","author":"Caplan","year":"1953","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb1120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/153537020623100506","article-title":"Alterations of Fas and Fas-related molecules in patients with silicosis","volume":"231","author":"Otsuki","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb1125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejim.2010.02.004","article-title":"Rheumatoid pneumoconiosis (Caplan\u2019s syndrome)","volume":"21","author":"Schreiber","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2020.102735_bb1130","first-page":"65","article-title":"Rheumatoid pneumoconiosis: a comparative study of autopsy cases between Japan and North America","volume":"46","author":"Honma","year":"2002","journal-title":"Ann Occup Hyg"},{"issue":"4","key":"10.1016\/j.autrev.2020.102735_bb1135","first-page":"261","article-title":"Immunological effects of silica and asbestos","volume":"4","author":"Otsuki","year":"2007","journal-title":"Cell Mol Immunol"},{"issue":"4848","key":"10.1016\/j.autrev.2020.102735_bb1140","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bmj.2.4848.1231","article-title":"An epidemiological study of rheumatoid arthritis associated with characteristic chest X-ray appearances in coal-workers","volume":"2","author":"Miall","year":"1953","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb1145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/14397595.2013.854076","article-title":"Silica exposure is associated with an increased risk of developing ACPA-positive rheumatoid arthritis in an Asian population: evidence from the Malaysian MyEIRA case-control study","volume":"24","author":"Yahya","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb1150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/thx.10.1.9","article-title":"Pathological studies of modified pneumoconiosis in coal-miners with rheumatoid arthritis; Caplan\u2019s syndrome","volume":"10","author":"Gough","year":"1955","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.autrev.2020.102735_bb1155","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1590\/S1806-37132009000900017","article-title":"Rheumatoid pneumoconiosis (Caplan\u2019s syndrome) with a classical presentation","volume":"35","author":"De Capitani","year":"2009","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.autrev.2020.102735_bb1160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1378\/chest.100.1.235","article-title":"Pulmonary manifestations associated with rheumatoid arthritis","volume":"100","author":"Helmers","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2020.102735_bb1165","first-page":"253","article-title":"Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope","volume":"26","author":"Lakos","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb1170","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.10096","article-title":"Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept","volume":"46","author":"Kekow","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2020.102735_bb1175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/BOR.0b013e32835f693f","article-title":"Extra-articular rheumatoid arthritis","volume":"25","author":"Turesson","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102735_bb1180","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3899\/jrheum.161103","article-title":"Severe extraarticular manifestations in a community-based cohort of patients with rheumatoid arthritis: risk factors and incidence in relation to treatment with tumor necrosis factor inhibitors","volume":"44","author":"Theander","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102735_bb1185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.rdc.2017.04.008","article-title":"Precision medicine in rheumatoid arthritis","volume":"43","author":"Bluett","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2020.102735_bb1190","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/rheumatology\/kev421","article-title":"Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability","volume":"55","author":"Cuppen","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102735_bb1195","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/520609a","article-title":"Personalized medicine: time for one-person trials","volume":"520","author":"Schork","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102508","article-title":"Precision health: a pragmatic approach to understanding and addressing key factors in autoimmune diseases","volume":"19","author":"Conrad","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb1205","doi-asserted-by":"crossref","first-page":"102506","DOI":"10.1016\/j.autrev.2020.102506","article-title":"Precision medicine in the care of rheumatoid arthritis: focus on prediction and prevention of future clinically-apparent disease","volume":"19","author":"Mahler","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb1210","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102509","article-title":"Personalized medicine in rheumatoid arthritis: how immunogenicity impacts use of TNF inhibitors","volume":"19","author":"Bodio","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2020.102735_bb1215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2018.08.003","article-title":"Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis","volume":"18","author":"Giacomelli","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2020.102735_bb1220","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","volume":"16","author":"Giacomelli","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2020.102735_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102514","article-title":"Usefulness of vasculitis biomarkers in the era of the personalized medicine","volume":"19","author":"Csernok","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102452","article-title":"EUSTAR co-authors. Outcomes of limited cutaneous systemic sclerosis patients: results on more than 12,000 patients from the EUSTAR database","volume":"19","author":"Frantz","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2020.102735_bb1235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2018.08.007","article-title":"Lymphomagenesis in Sj\u00f6gren\u2019s syndrome: predictive biomarkers towards precision medicine","volume":"18","author":"Goules","year":"2019","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220303165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220303165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:21:01Z","timestamp":1761600061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220303165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":246,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1568997220303165"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102735","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102735"}}